you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Dec 08, 16:00
4568.20 39.70 (0.88%)
Volume
AVERAGE VOLUME
5-Day
15,845
10-Day
18,888
30-Day
14,806
23,566
  • Prev. Close

    4528.50

  • Open Price

    4511.10

  • Bid Price (Qty.)

    4571.20 (10)

  • Offer Price (Qty.)

    4580.00 (47)

NSE Live

Dec 08, 15:59
4570.70 50.00 (1.11%)
Volume
AVERAGE VOLUME
5-Day
355,230
10-Day
543,723
30-Day
426,578
195,856
  • Prev. Close

    4520.70

  • Open Price

    4527.25

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.) Mar 21 Mar 20 Mar 19 Mar 18 Mar 17  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 13,281.40 11,803.00 10,572.90 9,302.60 9,628.10  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 13,281.40 11,803.00 10,572.90 9,302.60 9,628.10  
Total Operating Revenues 13,349.10 11,850.40 10,625.50 9,359.30 9,719.80  
Other Income 801.10 743.20 238.40 204.00 591.20  
Total Revenue 14,150.20 12,593.60 10,863.90 9,563.30 10,311.00  
EXPENSES  
Cost Of Materials Consumed 3,266.30 2,556.50 2,103.20 2,011.00 1,904.60  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -395.60 -99.90 66.00 -51.60 1.90  
Employee Benefit Expenses 2,270.10 2,030.20 1,931.90 1,843.00 1,803.30  
Finance Costs 46.70 47.80 56.80 62.80 57.20  
Depreciation And Amortisation Expenses 835.00 789.20 780.60 774.10 735.10  
Other Expenses 3,804.20 3,376.80 3,356.10 3,555.40 3,592.90  
Total Expenses 11,094.00 9,817.80 9,163.20 8,866.30 8,766.50  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 3,056.20 2,775.80 1,700.70 697.00 1,544.50  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 3,056.20 2,775.80 1,700.70 697.00 1,544.50  
Tax Expenses-Continued Operations  
Current Tax 540.10 483.90 281.80 138.10 182.60  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 329.70 -645.80 141.60 -8.00 -22.20  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 869.80 -161.90 423.40 130.10 160.40  
Profit/Loss After Tax And Before ExtraOrdinary Items 2,186.40 2,937.70 1,277.30 566.90 1,384.10  
Profit/Loss From Continuing Operations 2,186.40 2,937.70 1,277.30 566.90 1,384.10  
Profit/Loss For The Period 2,186.40 2,937.70 1,277.30 566.90 1,384.10  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 131.84 177.23 76.98 34.19 83.05  
Diluted EPS (Rs.) 131.46 176.88 76.85 34.12 82.88  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 414.70 391.40 332.00 399.20 335.30  
Tax On Dividend 0.00 0.00 68.20 0.00 0.00  
Equity Dividend Rate (%) 500.00 500.00 400.00 400.00 400.00  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs